FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

People Dont Understand Drug Label Instructions

[ Price : $8.95]

Researchers from the American College of Physicians say the text and format of Rx drug labels should be redesigned and standardize...

Latest FDA-483s, EIRs Received from FDA

[ Price : $8.95]

We post inspection documents for BioMed International, Chemrich, Cincinnati Sub-Zero, Eqyss, June Jacobs, Pascal Co., Peoples Phar...

Stents Associated with Increased Thrombosis Risk

[ Price : $8.95]

A Cleveland Clinic analysis shows a small but real increased risk of late stent thrombosis when drug-eluting stents are used.

Teva Educating on Inhaler Switch

[ Price : $8.95]

Teva says it is working with the American Lung Association on educating asthma patients about conversion from CFC-containing albut...

FDA Panel Backs Celebrex in Juvenile RA

[ Price : $8.95]

FDAs Arthritis Drugs Advisory Committee 11/29 votes to recommend approval of Pfizers Celebrex (celecoxib) for use in juvenile rheu...

FDA Chief of Staff Patrick Ronan Resigns

[ Price : $8.95]

After 2 years at FDA, chief of staff Patrick Ronan resigns to recharge my batteries and spend time with his family before deciding...

Famulare, Friedman Promoted at CDER

[ Price : $8.95]

CDER Division of Manufacturing and Product Quality (DMPQ) director Joe Famulare moves up the ladder to Office of Compliance deputy...

Committee to Discuss Creutzfeldt-Jakob Risk

[ Price : $8.95]

Federal Register Notice: FDAs Transmissible Spongiform Encephalopathies Advisory Committee will meet 12/15 to discuss risk for exp...

Mylan Bertek Name Changed

[ Price : $8.95]

Federal Register Final rule: FDAs animal drug regulations are changed to reflect a sponsor name change to Mylan Bertek Pharmaceuti...

Lunesta Most Recognized TV Drug Ad

[ Price : $8.95]

IAG Research says Lunesta produced the most recalled drug TV ad in the last season.